Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 14/20 | 0.44 |
| ▸ | GBA1 | P04062 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8743759 | 0.85 | OTC (0.36) | ACHEMEN1KMT2A | |
| SCHEMBL8743764 | 0.85 | OTC (0.36) | ACHEMEN1KMT2A | |
| SCHEMBL8575199 | 0.84 | ACHE (0.50) | ACHE | |
| SCHEMBL8576974 | 0.84 | ACHE (0.50) | ACHE | |
| SCHEMBL8578551 | 0.84 | ACHE (0.50) | ACHE | |
| SCHEMBL8574234 | 0.84 | ACHE (0.50) | ACHE | |
| SCHEMBL8575651 | 0.84 | ACHE (0.50) | ACHE | |
| SCHEMBL8579534 | 0.84 | ACHE (0.50) | ACHE | |
| SCHEMBL8575788 | 0.84 | ACHE (0.50) | ACHE | |
| SCHEMBL8580673 | 0.84 | ACHE (0.50) | ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11702554-B2 | Compound for release agent and method for preparing the same | CEKO CO., LTD. (KR) | 2023-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11702554-B2 | Compound for release agent and method for preparing the same | NSF, CRH, CDC37 | ACHE 380/4885GBA1 720/4885MEN1 841/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.